ERBB2 and Pruritus: A total of 122 female patients (median age at pruritus onset 54.5, range 28–88) with a diagnosis of HER2 + breast cancer who experienced pruritus attributed to HP from 11/23/2011 to 6/21/2021 were included in this study (Table 1).